142 related articles for article (PubMed ID: 33394592)
1. Cumulative Efficacy of Longitudinal Repeat Salivary Gland OnabotulinumtoxinA Injection: A Retrospective Study.
Shoval H; Friel K; Levin J; Kim H
Am J Phys Med Rehabil; 2021 Aug; 100(8):798-802. PubMed ID: 33394592
[TBL] [Abstract][Full Text] [Related]
2. Safety of combined salivary gland and multilevel intramuscular onabotulinumtoxinA injections with and without ethanol in pediatric patients with cerebral palsy: A retrospective study.
Shoval H; Levin J; Friel K; Kim H
J Pediatr Rehabil Med; 2019; 12(2):189-196. PubMed ID: 31227667
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
[TBL] [Abstract][Full Text] [Related]
4. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
5. Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands.
Berweck S; Schroeder AS; Lee SH; Bigalke H; Heinen F
Dev Med Child Neurol; 2007 Jan; 49(1):62-4. PubMed ID: 17209979
[TBL] [Abstract][Full Text] [Related]
6. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
[TBL] [Abstract][Full Text] [Related]
8. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands.
Jongerius PH; Joosten F; Hoogen FJ; Gabreels FJ; Rotteveel JJ
Laryngoscope; 2003 Jan; 113(1):107-11. PubMed ID: 12514392
[TBL] [Abstract][Full Text] [Related]
9. Effects of salivary gland botulinum Toxin-A on drooling and respiratory morbidity in children with neurological dysfunction.
Gubbay A; Marie Blackmore A
Int J Pediatr Otorhinolaryngol; 2019 Sep; 124():124-128. PubMed ID: 31185343
[TBL] [Abstract][Full Text] [Related]
10. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
Vaile L; Finlay F
Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361
[No Abstract] [Full Text] [Related]
11. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
[TBL] [Abstract][Full Text] [Related]
12. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.
Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C
J Oral Maxillofac Surg; 2003 Apr; 61(4):454-7. PubMed ID: 12684962
[TBL] [Abstract][Full Text] [Related]
13. Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review.
Rodwell K; Edwards P; Ware RS; Boyd R
Dev Med Child Neurol; 2012 Nov; 54(11):977-87. PubMed ID: 22946706
[TBL] [Abstract][Full Text] [Related]
14. The impact of botulinum toxin type A in the treatment of drooling in children with cerebral palsy secondary to Congenital Zika Syndrome: an observational study.
Sales HF; Cerqueira C; Vaz D; Medeiros-Rios D; Armani-Franceschi G; Lucena PH; Sternberg C; Nóbrega AC; Luz C; Fonseca D; Carvalho AL; Monteiro L; Siqueira IC; Bandeira ID; Lucena R
Neurol Res; 2021 Jan; 43(1):54-60. PubMed ID: 32915712
[TBL] [Abstract][Full Text] [Related]
15. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A as a treatment for excessive drooling in children.
Bothwell JE; Clarke K; Dooley JM; Gordon KE; Anderson R; Wood EP; Camfield CS; Camfield PR
Pediatr Neurol; 2002 Jul; 27(1):18-22. PubMed ID: 12160968
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy.
Lin YC; Shieh JY; Cheng ML; Yang PY
Neurology; 2008 Jan; 70(4):316-8. PubMed ID: 18209205
[No Abstract] [Full Text] [Related]
18. Sialorrhea & aspiration control - A minimally invasive strategy uncomplicated by anticholinergic drug tolerance or tachyphylaxis.
Dohar JE
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():97-101. PubMed ID: 30554718
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
Costa J; Rocha ML; Ferreira J; Evangelista T; Coelho M; de Carvalho M
J Neurol; 2008 Apr; 255(4):545-50. PubMed ID: 18283399
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
Jongerius PH; Rotteveel JJ; van Limbeek J; Gabreëls FJ; van Hulst K; van den Hoogen FJ
Neurology; 2004 Oct; 63(8):1371-5. PubMed ID: 15505151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]